Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms do not affect early functional and structural changes in atherosclerosis - The Cardiovascular Risk In Young Finns Study

Circulation Journal

Volumn 71, Issue 5, 2007, Pages 741-745

  Nieminen, Tuomo ^a,g   Kähönen, Mika ^a   Islam, Md Shaheenul ^a,b   Raitakari, Olli T ^c   Hutri Kähönen, Nina ^a   Marniemi, Jukka ^d   Juonala, Markus ^e   Rontu, Riikka ^a   Viikari, Jorma ^f   Lehtimäki, Terho ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b GEORGE INSTITUTE FOR INTERNATIONAL HEALTH   (Australia)

^c UNIVERSITY OF TURKU   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY OF TURKU   (Finland)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

^g TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Apolipoprotein; Arterial compliance; Carotid artery; Flow mediated vasodilatation; Media intima thickness; Polymorphism

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; C REACTIVE PROTEIN;

ADOLESCENT; ADULT; ARTERY BLOOD FLOW; ARTERY COMPLIANCE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ARTERY; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; SSTI GENE; TUNICA MEDIA; VASCULAR PATENCY; VASODILATATION; XBAI GENE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-III; APOLIPOPROTEINS; APOLIPOPROTEINS A; APOLIPOPROTEINS B; ATHEROSCLEROSIS; BRACHIAL ARTERY; CAROTID ARTERIES; CHILD; CHILD, PRESCHOOL; COMPLIANCE; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; POLYMORPHISM, GENETIC; REGIONAL BLOOD FLOW; TUNICA INTIMA; TUNICA MEDIA; VASODILATION;

EID: 34247647094     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.741     Document Type: Article

References (30)

1. O'Leary DH, Polak JF. Intima-media thickness: A tool for atherosclerosis imaging and event prediction. Am J Cardiol 2002; 90: 18L-21L.
2. Raitakari OT. Imaging of subclinical atherosclerosis in children and young adults. Ann Med 1999; 31(Suppl 1): 33-40.
3. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146: 483-494.
4. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 1995; 26: 386-391.
5. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991; 11: 1245-1249.
6. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 1997; 96: 1432-1437.
7. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003; 23: 554-566.
8. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-175.
9. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients: A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 1988; 70: 253-261.
10. Gariepy J, Simon A, Massonneau M, Linhart A, Levenson J. Wall thickening of carotid and femoral arteries in male subjects with isolated hypercholesterolemia: PCVMETRA Group (Prevention Cardio-Vasculaire en Medecine du Travail). Atherosclerosis 1995; 113: 141-151.
11. Song Y, Stampfer MJ, Liu S. Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 2004; 141: 137-147.
12. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review. Am J Epidemiol 2002; 155: 487-495.
13. Nieminen T, Kähönen M, Lehtimäki T. The effects of apoA-I/C-III/A-IV, apoE and apoB polymorphisms on carotid artery intima-media thickness. Future Cardiol 2006; 2: 179-186.
14. Seilhamer JJ, Protter AA, Frossard P, Levy-Wilson B. Isolation and DNA sequence of full-length cDNA and of the entire gene for human apolipoprotein AI-discovery of a new genetic polymorphism in the apo AI gene. DNA 1984; 3: 309-317.
15. Rees A, Shoulders CC, Stocks J, Galton DJ, Baralle FE. DNA polymorphism adjacent to human apoprotein A-1 gene: Relation to hypertriglyceridaemia. Lancet 1983; 1: 444-446.
16. Bai H, Saku K, Liu R, Imamura M, Arakawa K. Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population. Hum Genet 1995; 95: 102-104.
17. Marshall HW, Morrison LC, Wu LL, Anderson JL, Corneli PS, Stauffer DM, et al. Apolipoprotein polymorphisms fail to define risk of coronary artery disease: Results of a prospective, angiographically controlled study. Circulation 1994; 89: 567-577.
18. Ferns GA, Galton DJ. Haplotypes of the human apoprotein AI-CIII-AIV gene cluster in coronary atherosclerosis. Hum Genet 1986; 73: 245-249.
19. Chen X, Tian H, Liu R. Association of serum apolipoprotein C III levels and apolipoprotein C III gene Sst I polymorphism with carotid intima-media thickness in Chinese type 2 diabetic patients. Diabetes Res Clin Pract 2004; 66: 41-47.
20. Islam MS, Raitakari OT, Juonala M, Kähönen M, Hutri-Kähönen N, Collings A, et al. Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms and their association with carotid artery intima-media thickness in the Finnish population: The Cardiovascular Risk in Young Finns Study. Atherosclerosis 2005; 180: 79-86.
21. Chiodini BD, Barlera S, Franzosi MG, Beceiro VL, Introna M, Tognoni G. APO B gene polymorphisms and coronary artery disease: A meta-analysis. Atherosclerosis 2003; 167: 355-366.
22. Åkerblom HK, Viikari J, Raitakari OT, Uhari M. Cardiovascular Risk in Young Finns Study: General outline and recent developments. Ann Med 1999; 31(Suppl 1): 45-54.
23. Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Maki-Torkko N, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study. JAMA 2003; 290: 2277-2283.
24. Åkerblom HK, Viikari J, Uhari M, Räsänen L, Byckling T, Louhivuori K, et al. Atherosclerosis precursors in Finnish children and adolescents. I: General description of the cross-sectional study of 1980, and an account of the children's and families' state of health. Acta Paediatr Scand Suppl 1985; 318: 49-63.
25. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999; 14: 143-149.
26. Aalto-Setälä K, Viikari J, Åkerblom HK, Kuusela V, Kontula K. DNA polymorphisms of the apolipoprotein B and A-I/C-III genes are associated with variations of serum low density lipoprotein cholesterol level in childhood. J Lipid Res 1991; 32: 1477-1487.
27. Juonala M, Jarvisalo MJ, Maki-Torkko N, Kahonen M, Viikari JS, Raitakari OT. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: The Cardiovascular Risk in Young Finns Study. Circulation 2005; 112: 1486-1493.
28. Juonala M, Viikari JS, Kähönen M, Taittonen L, Ronnemaa T, Laitinen T, et al. Geographic origin as a determinant of carotid artery intima-media thickness and brachial artery flow-mediated dilation: The Cardiovascular Risk in Young Finns study. Arterioscler Thromb Vasc Biol 2005; 25: 392-398.
29. Comings DE, MacMurray JP. Molecular heterosis: A review. Mol Genet Metab 2000; 71: 19-31.
30. Ordovas JM, Civeira F, Genest J Jr, Craig S, Robbins AH, Meade T, et al. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus: Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis 1991; 87: 75-86.